HEADER LIGASE/LIGASE INHIBITOR 21-AUG-12 4GPL TITLE STRUCTURE OF CBL(TKB) BOUND TO A PHOSPHORYLATED PENTAPEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACE-PTR-THR-PRO-GLU-PRO, PEPTIDE INHIBITOR; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: E3 UBIQUITIN-PROTEIN LIGASE CBL; COMPND 7 CHAIN: B; COMPND 8 FRAGMENT: HUMAN CBL TKB DOMAIN RESIDUES 47-351; COMPND 9 SYNONYM: CASITAS B-LINEAGE LYMPHOMA PROTO-ONCOGENE, PROTO-ONCOGENE C- COMPND 10 CBL, RING FINGER PROTEIN 55, SIGNAL TRANSDUCTION PROTEIN CBL; COMPND 11 EC: 6.3.2.-; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 MOL_ID: 2; SOURCE 4 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 5 ORGANISM_COMMON: HUMAN; SOURCE 6 ORGANISM_TAXID: 9606; SOURCE 7 GENE: CBL, CBL2, RNF55; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 10 EXPRESSION_SYSTEM_STRAIN: ROSETTA-2; SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS UBIQUITIN LIGASE(E3), LIGASE-LIGASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR G.BORGSTAHL,A.NATARAJAN REVDAT 3 06-DEC-23 4GPL 1 REMARK REVDAT 2 13-SEP-23 4GPL 1 SEQADV LINK REVDAT 1 18-SEP-13 4GPL 0 JRNL AUTH E.A.KUMAR,Q.CHEN,S.KIZHAKE,C.KOLAR,M.KANG,C.E.CHANG, JRNL AUTH 2 G.E.BORGSTAHL,A.NATARAJAN JRNL TITL THE PARADOX OF CONFORMATIONAL CONSTRAINT IN THE DESIGN OF JRNL TITL 2 CBL(TKB)-BINDING PEPTIDES. JRNL REF SCI REP V. 3 1639 2013 JRNL REFN ESSN 2045-2322 JRNL PMID 23572190 JRNL DOI 10.1038/SREP01639 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.66 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 9213 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 470 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.08 REMARK 3 REFLECTION IN BIN (WORKING SET) : 646 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2580 REMARK 3 BIN FREE R VALUE SET COUNT : 30 REMARK 3 BIN FREE R VALUE : 0.3870 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2547 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 41 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 47.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.75 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.00000 REMARK 3 B22 (A**2) : -2.00000 REMARK 3 B33 (A**2) : 3.00000 REMARK 3 B12 (A**2) : -1.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.404 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.301 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 17.092 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.941 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.891 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2616 ; 0.012 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3537 ; 1.685 ; 1.971 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 308 ; 6.497 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 120 ;36.620 ;23.417 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 464 ;22.866 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 17 ;19.296 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 375 ; 0.106 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1974 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT REMARK 4 REMARK 4 4GPL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-AUG-12. REMARK 100 THE DEPOSITION ID IS D_1000074478. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : JUL-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : VARIMAX HIGHRES OPTICS REMARK 200 OPTICS : VARIMAX HIGHRES OPTICS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38058 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 32.660 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 3.930 REMARK 200 R MERGE (I) : 0.16100 REMARK 200 R SYM (I) : 0.18500 REMARK 200 FOR THE DATA SET : 6.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.93 REMARK 200 R MERGE FOR SHELL (I) : 0.44200 REMARK 200 R SYM FOR SHELL (I) : 0.51200 REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2CBL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 63.13 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.25M POTASSIUM SODIUM TARTRATE REMARK 280 TETRAHYDRATE, 20% W/V PEG 3350, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 6 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z REMARK 290 6555 X-Y,X,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1180 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15460 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9050 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 40860 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -45.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 61.28700 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 -106.15220 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 122.57400 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY B 43 REMARK 465 SER B 44 REMARK 465 HIS B 45 REMARK 465 MET B 46 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 11 CA - C - N ANGL. DEV. = -17.2 DEGREES REMARK 500 PRO A 11 O - C - N ANGL. DEV. = 9.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN B 79 33.81 -87.49 REMARK 500 PRO B 81 120.02 -37.16 REMARK 500 TYR B 102 47.79 -89.04 REMARK 500 LYS B 105 33.49 -70.82 REMARK 500 LYS B 134 -70.25 -75.15 REMARK 500 LYS B 137 -111.44 25.70 REMARK 500 ASP B 234 16.68 56.77 REMARK 500 ALA B 262 -54.45 -121.34 REMARK 500 ALA B 270 -90.41 -75.54 REMARK 500 PHE B 271 69.49 -107.79 REMARK 500 ARG B 299 66.69 -113.58 REMARK 500 ASP B 341 27.42 37.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN A OF ACE-PTR-THR-PRO-GLU REMARK 800 -PRO, PEPTIDE INHIBITOR DBREF 4GPL B 47 351 UNP P22681 CBL_HUMAN 47 351 DBREF 4GPL A 6 12 PDB 4GPL 4GPL 6 12 SEQADV 4GPL GLY B 43 UNP P22681 EXPRESSION TAG SEQADV 4GPL SER B 44 UNP P22681 EXPRESSION TAG SEQADV 4GPL HIS B 45 UNP P22681 EXPRESSION TAG SEQADV 4GPL MET B 46 UNP P22681 EXPRESSION TAG SEQRES 1 A 7 ACE PTR THR PRO GLU PRO NH2 SEQRES 1 B 309 GLY SER HIS MET PRO PRO GLY THR VAL ASP LYS LYS MET SEQRES 2 B 309 VAL GLU LYS CYS TRP LYS LEU MET ASP LYS VAL VAL ARG SEQRES 3 B 309 LEU CYS GLN ASN PRO LYS LEU ALA LEU LYS ASN SER PRO SEQRES 4 B 309 PRO TYR ILE LEU ASP LEU LEU PRO ASP THR TYR GLN HIS SEQRES 5 B 309 LEU ARG THR ILE LEU SER ARG TYR GLU GLY LYS MET GLU SEQRES 6 B 309 THR LEU GLY GLU ASN GLU TYR PHE ARG VAL PHE MET GLU SEQRES 7 B 309 ASN LEU MET LYS LYS THR LYS GLN THR ILE SER LEU PHE SEQRES 8 B 309 LYS GLU GLY LYS GLU ARG MET TYR GLU GLU ASN SER GLN SEQRES 9 B 309 PRO ARG ARG ASN LEU THR LYS LEU SER LEU ILE PHE SER SEQRES 10 B 309 HIS MET LEU ALA GLU LEU LYS GLY ILE PHE PRO SER GLY SEQRES 11 B 309 LEU PHE GLN GLY ASP THR PHE ARG ILE THR LYS ALA ASP SEQRES 12 B 309 ALA ALA GLU PHE TRP ARG LYS ALA PHE GLY GLU LYS THR SEQRES 13 B 309 ILE VAL PRO TRP LYS SER PHE ARG GLN ALA LEU HIS GLU SEQRES 14 B 309 VAL HIS PRO ILE SER SER GLY LEU GLU ALA MET ALA LEU SEQRES 15 B 309 LYS SER THR ILE ASP LEU THR CYS ASN ASP TYR ILE SER SEQRES 16 B 309 VAL PHE GLU PHE ASP ILE PHE THR ARG LEU PHE GLN PRO SEQRES 17 B 309 TRP SER SER LEU LEU ARG ASN TRP ASN SER LEU ALA VAL SEQRES 18 B 309 THR HIS PRO GLY TYR MET ALA PHE LEU THR TYR ASP GLU SEQRES 19 B 309 VAL LYS ALA ARG LEU GLN LYS PHE ILE HIS LYS PRO GLY SEQRES 20 B 309 SER TYR ILE PHE ARG LEU SER CYS THR ARG LEU GLY GLN SEQRES 21 B 309 TRP ALA ILE GLY TYR VAL THR ALA ASP GLY ASN ILE LEU SEQRES 22 B 309 GLN THR ILE PRO HIS ASN LYS PRO LEU PHE GLN ALA LEU SEQRES 23 B 309 ILE ASP GLY PHE ARG GLU GLY PHE TYR LEU PHE PRO ASP SEQRES 24 B 309 GLY ARG ASN GLN ASN PRO ASP LEU THR GLY MODRES 4GPL PTR A 7 TYR O-PHOSPHOTYROSINE HET ACE A 6 3 HET PTR A 7 16 HET NH2 A 12 1 HETNAM ACE ACETYL GROUP HETNAM PTR O-PHOSPHOTYROSINE HETNAM NH2 AMINO GROUP HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 ACE C2 H4 O FORMUL 1 PTR C9 H12 N O6 P FORMUL 1 NH2 H2 N FORMUL 3 HOH *41(H2 O) HELIX 1 1 ASP B 52 GLN B 71 1 20 HELIX 2 2 ASN B 72 ALA B 76 5 5 HELIX 3 3 TYR B 83 TYR B 102 1 20 HELIX 4 4 ASN B 112 GLY B 136 1 25 HELIX 5 5 LYS B 137 TYR B 141 5 5 HELIX 6 6 SER B 145 PHE B 169 1 25 HELIX 7 7 PRO B 170 LEU B 173 5 4 HELIX 8 8 GLN B 175 PHE B 179 5 5 HELIX 9 9 LYS B 183 GLY B 195 1 13 HELIX 10 10 TRP B 202 GLU B 211 1 10 HELIX 11 11 SER B 217 ASP B 229 1 13 HELIX 12 12 VAL B 238 PHE B 248 1 11 HELIX 13 13 PRO B 250 SER B 252 5 3 HELIX 14 14 SER B 253 ALA B 262 1 10 HELIX 15 15 THR B 273 LYS B 283 1 11 HELIX 16 16 PRO B 323 GLU B 334 1 12 SHEET 1 A 2 ILE B 199 PRO B 201 0 SHEET 2 A 2 TYR B 235 SER B 237 -1 O ILE B 236 N VAL B 200 SHEET 1 B 4 ILE B 314 THR B 317 0 SHEET 2 B 4 TRP B 303 VAL B 308 -1 N ILE B 305 O THR B 317 SHEET 3 B 4 SER B 290 LEU B 295 -1 N ARG B 294 O ALA B 304 SHEET 4 B 4 PHE B 339 PRO B 340 1 O PHE B 339 N TYR B 291 LINK C ACE A 6 N PTR A 7 1555 1555 1.34 LINK C PTR A 7 N THR A 8 1555 1555 1.32 LINK C PRO A 11 N NH2 A 12 1555 1555 1.28 CISPEP 1 PRO B 81 PRO B 82 0 4.27 CISPEP 2 GLN B 249 PRO B 250 0 -2.31 SITE 1 AC1 16 HOH A 101 TYR B 274 ARG B 294 SER B 296 SITE 2 AC1 16 CYS B 297 THR B 298 ARG B 299 TYR B 307 SITE 3 AC1 16 GLN B 316 THR B 317 HIS B 320 LYS B 322 SITE 4 AC1 16 PHE B 336 TYR B 337 HOH B 412 HOH B 417 CRYST1 122.574 122.574 56.231 90.00 90.00 120.00 P 6 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008158 0.004710 0.000000 0.00000 SCALE2 0.000000 0.009420 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017784 0.00000 HETATM 1 C ACE A 6 58.704 -41.920 -4.794 1.00 20.35 C HETATM 2 O ACE A 6 58.636 -42.902 -5.529 1.00 20.12 O HETATM 3 CH3 ACE A 6 58.844 -42.095 -3.294 1.00 18.65 C HETATM 4 N PTR A 7 58.187 -40.771 -5.234 1.00 21.17 N HETATM 5 CA PTR A 7 57.670 -40.753 -6.650 1.00 22.06 C HETATM 6 C PTR A 7 58.776 -40.304 -7.565 1.00 22.46 C HETATM 7 O PTR A 7 59.720 -39.644 -7.145 1.00 22.95 O HETATM 8 CB PTR A 7 56.435 -39.859 -6.787 1.00 23.22 C HETATM 9 CG PTR A 7 55.326 -40.392 -5.896 1.00 25.27 C HETATM 10 CD1 PTR A 7 54.470 -41.382 -6.359 1.00 25.99 C HETATM 11 CD2 PTR A 7 55.148 -39.917 -4.601 1.00 26.26 C HETATM 12 CE1 PTR A 7 53.461 -41.864 -5.542 1.00 26.79 C HETATM 13 CE2 PTR A 7 54.141 -40.424 -3.775 1.00 26.84 C HETATM 14 CZ PTR A 7 53.280 -41.401 -4.245 1.00 27.29 C HETATM 15 OH PTR A 7 52.263 -41.970 -3.490 1.00 29.37 O HETATM 16 P PTR A 7 51.692 -41.561 -2.030 1.00 29.68 P HETATM 17 O1P PTR A 7 52.800 -41.693 -1.008 1.00 31.50 O HETATM 18 O2P PTR A 7 50.617 -42.582 -1.830 1.00 32.22 O HETATM 19 O3P PTR A 7 51.173 -40.160 -2.285 1.00 31.05 O